Clinical Trials Browser

Recruiting × tislelizumab × Lymphoid × Clear all

NCT07418190 2026-02-18

Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular

NCT05977673 2025-12-08

FIL_Tisle-HL

Phase 2 Recruiting

Hodgkin Disease, Lymphoma

NCT05477264 2024-04-03

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Phase 2 Recruiting

Lymphoma

NCT05659628 2022-12-21

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

Phase 1 Recruiting

Lymphoma, Large B-Cell, Diffuse